Feasibility of low dose interleukin-2 therapy following T cell-depleted non-myeloablative allogeneic hematopoietic stem cell transplantation from HLA matched or mismatched family member donors

High relapse rates and infections remain primary causes of failure in non-myeloablative transplantation. Interleukin-2 (IL-2) may stimulate the immune system and improve outcomes. The primary objective of this pilot study was to evaluate the feasibility of administering IL-2 following a T cell-deple...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Rizzieri, David A., Crout, Christopher, Storms, Robert, Golob, Jared, Long, Gwynn D., Gasparetto, Cristina, Sullivan, Keith M., Horwitz, Mitchell, Chute, John, Lagoo, Anand S., Morris, Ashley, Beaven, Anne, Yang, Yiping, Peterson, Bercedis, Li, Zhiguo, Chao, Nelson J.
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3619422/
https://ncbi.nlm.nih.gov/pubmed/21166499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/07357907.2010.535055
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares